Key result
Cyclosporine A treatment reduced cardiac necrosis and calcification by more than half in Abcc6-deficient mice following Coxsackievirus B3 infection by inhibiting cyclophilin D.
Why the study?
Does cyclosporine A reduce cardiac necrosis and calcification in Abcc6-deficient mice infected with Coxsackievirus B3?
Does cyclosporine A reduce cardiac necrosis and calcification in Abcc6-deficient mice infected with Coxsackievirus B3?
Answers are grounded in this paper and cite their sources.
In a mouse model of Coxsackievirus B3 infection, Abcc6 deficiency increases susceptibility to cardiac calcification and necrosis, which can be mitigated by inhibiting cyclophilin D with Cyclosporine A.
Coxsackievirus type B3 (CVB3) is a cardiotropic enterovirus. Infection causes cardiomyocyte necrosis and myocardial inflammation. The damaged tissue that results is replaced with fibrotic or calcified tissue, which can lead to permanently altered cardiac function. The extent of pathogenesis among individuals exposed to CVB3 is dictated by a combination of host genetics, viral virulence, and the environment. Here, we aimed to identify genes that modulate cardiopathology following CVB3 infection. 129S1 mice infected with CVB3 developed increased cardiac pathology compared to 129X1 substrain mice despite no difference in viral burden. Linkage analysis identified a major locus on chromosome 7 (LOD: 8.307, P<0.0001) that controlled the severity of cardiac calcification and necrosis following infection. Sub-phenotyping and genetic complementation assays identified Abcc6 as the underlying gene. Microarray expression profiling identified genotype-dependent regulation of genes associated with mitochondria. Electron microscopy examination showed elevated deposition of hydroxyapatite-like material in the mitochondrial matrices of infected Abcc6 knockout (Abcc6-/-) mice but not in wildtype littermates. Cyclosporine A (CsA) inhibits mitochondrial permeability transition pore opening by inhibiting cyclophilin D (CypD). Treatment of Abcc6 -/- mice with CsA reduced cardiac necrosis and calcification by more than half. Furthermore, CsA had no effect on the CVB3-induced phenotype of doubly deficient CypD-/-Abcc6-/- mice. Altogether, our work demonstrates that mutations in Abcc6 render mice more susceptible to cardiac calcification following CVB3 infection. Moreover, we implicate CypD in the control of cardiac necrosis and calcification in Abcc6-deficient mice, whereby CypD inhibition is required for cardioprotection.
No takes yet. Share an insight, caveat, or question.
Marton et al. (2015) studied Coxsackievirus B3 Infection. Cyclosporine A vs. Vehicle (1% DMSO in corn oil) was evaluated on Cardiac necrosis and calcification. Cyclosporine A treatment reduced cardiac necrosis and calcification by more than half in Abcc6-deficient mice following Coxsackievirus B3 infection by inhibiting cyclophilin D.
Synapse has enriched 10 related papers. Consider them for comparative context: